Home LiteratureArticle Details
PMID: 16314532 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

The class II phosphoinositide 3-kinase C2beta is not essential for epidermal differentiation.

Molecular and cellular biology ·Vol. 25 ·No. 24 ·2005-12-00 ·Pages 11122-30

Harada K, Truong AB, Cai T, Khavari PA

Abstract

Phosphoinositide 3-kinases (PI3Ks) regulate an array of cellular processes and are comprised of three classes. Class I PI3Ks include the well-studied agonist-sensitive p110 isoforms; however, the functions of class II and III PI3Ks are less well characterized. Of the three class II PI3Ks, C2alpha and C2beta are widely expressed in many tissues, including the epidermis, while C2gamma is confined to the liver. In contrast to the class I PI3K p110alpha, which is expressed throughout the epidermis, C2beta was found to be localized in suprabasal cells, suggesting a potential role for C2beta in epidermal differentiation. Overexpressing C2beta in epidermal cells in vitro induced differentiation markers. To study a role for C2beta in tissue, we generated transgenic mice overexpressing C2beta in both suprabasal and basal epidermal layers. These mice lacked epidermal abnormalities. Mice deficient in C2beta were then generated by targeted gene deletion. C2beta knockout mice were viable and fertile and displayed normal epidermal growth, differentiation, barrier function, and wound healing. To exclude compensation by C2alpha, RNA interference was then used to knock down both C2alpha and C2beta in epidermal cells simultaneously. Induction of differentiation markers was unaffected in the absence of C2alpha and C2beta. These findings indicate that class II PI3Ks are not essential for epidermal differentiation.

MeSH Terms
Animals Cell Differentiation/genetics Cells, Cultured Class II Phosphatidylinositol 3-Kinases Epidermal Cells Epidermis/enzymology Gene Deletion Humans Mice Mice, Knockout Mice, Transgenic Mutation Phosphatidylinositol 3-Kinases/genetics,metabolism Phosphoinositide-3 Kinase Inhibitors RNA Interference Transcriptional Activation Wound Healing/genetics
Chemicals
Phosphoinositide-3 Kinase Inhibitors Class II Phosphatidylinositol 3-Kinases PIK3C2B protein, human
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Harada Kazutoshi
Veterans Affairs Palo Alto Healthcare System, CA 94304, USA.
Truong Amy B
Cai Ti
Khavari Paul A
References (33)
33 references, click to expand
  1. Growth factor regulation of the novel class II phosphoinositide 3-kinases.
    Biochem Soc Trans. 2001 Aug;29(Pt 4):535-7 PMID: 11498023
  2. Human phosphoinositide 3-kinase C2beta, the role of calcium and the C2 domain in enzyme activity.
    J Biol Chem. 1998 Dec 4;273(49):33082-90 PMID: 9830063
  3. Class I phosphoinositide 3-kinases.
    Int J Biochem Cell Biol. 2003 Jul;35(7):1028-33 PMID: 12672472
  4. Topical treatment with inhibitors of the phosphatidylinositol 3'-kinase/Akt and Raf/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathways reduces melanoma development in severe combined immunodeficient mice.
    Cancer Res. 2004 Apr 1;64(7):2552-60 PMID: 15059911
  5. Nuclear phosphoinositide 3-kinase C2beta activation during G2/M phase of the cell cycle in HL-60 cells.
    Biochim Biophys Acta. 2003 Feb 20;1631(1):61-71 PMID: 12573450
  6. Role of phosphoinositide 3-kinase in activation of ras and mitogen-activated protein kinase by epidermal growth factor.
    Mol Cell Biol. 1999 Jun;19(6):4279-88 PMID: 10330169
  7. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002.
    EMBO J. 1996 Oct 1;15(19):5256-67 PMID: 8895571
  8. Class II phosphoinositide 3-kinase defines a novel signaling pathway in cell migration.
    J Cell Biol. 2005 Jun 6;169(5):789-99 PMID: 15928202
  9. Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice.
    Proc Natl Acad Sci U S A. 1989 Mar;86(5):1563-7 PMID: 2466292
  10. The class II phosphoinositide 3-kinase C2alpha is activated by clathrin and regulates clathrin-mediated membrane trafficking.
    Mol Cell. 2001 Feb;7(2):443-9 PMID: 11239472
  11. Corrective gene transfer in the human skin disorder lamellar ichthyosis.
    Nat Med. 1996 Nov;2(11):1263-7 PMID: 8898758
  12. 1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells.
    Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7415-9 PMID: 8052599
  13. Hepatocyte growth factor activates phosphoinositide 3-kinase C2 beta in renal brush-border plasma membranes.
    Biochem J. 2002 Aug 1;365(Pt 3):791-9 PMID: 11931646
  14. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002).
    J Biol Chem. 1994 Feb 18;269(7):5241-8 PMID: 8106507
  15. The CC chemokine monocyte chemotactic peptide-1 activates both the class I p85/p110 phosphatidylinositol 3-kinase and the class II PI3K-C2alpha.
    J Biol Chem. 1998 Oct 2;273(40):25987-95 PMID: 9748276
  16. Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer.
    Annu Rev Cell Dev Biol. 2001;17:615-75 PMID: 11687500
  17. Induction of epidermal hyperplasia, hyperkeratosis, and papillomas in transgenic mice by a targeted v-Ha-ras oncogene.
    Mol Carcinog. 1993;7(2):99-110 PMID: 7681293
  18. Cloning of a human phosphoinositide 3-kinase with a C2 domain that displays reduced sensitivity to the inhibitor wortmannin.
    Biochem J. 1997 Aug 15;326 ( Pt 1):139-47 PMID: 9337861
  19. The phosphoinositide (PI) 3-kinase family.
    J Cell Sci. 2003 Aug 1;116(Pt 15):3037-40 PMID: 12829733
  20. The activation of nuclear phosphoinositide 3-kinase C2beta in all-trans-retinoic acid-differentiated HL-60 cells.
    FEBS Lett. 2002 Oct 9;529(2-3):268-74 PMID: 12372612
  21. High frequency of mutations of the PIK3CA gene in human cancers.
    Science. 2004 Apr 23;304(5670):554 PMID: 15016963
  22. High-efficiency gene transfer and pharmacologic selection of genetically engineered human keratinocytes.
    Biotechniques. 1998 Aug;25(2):274-80 PMID: 9714888
  23. Calcium-induced human keratinocyte differentiation requires src- and fyn-mediated phosphatidylinositol 3-kinase-dependent activation of phospholipase C-gamma1.
    Mol Biol Cell. 2005 Jul;16(7):3236-46 PMID: 15872086
  24. In vivo restoration of laminin 5 beta 3 expression and function in junctional epidermolysis bullosa.
    Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5193-8 PMID: 11296269
  25. Phosphatidylinositol 3-kinase is a key regulator of early phase differentiation in keratinocytes.
    J Biol Chem. 2002 Oct 25;277(43):40390-6 PMID: 12183446
  26. Two distinct phosphoinositide 3-kinases mediate polypeptide growth factor-stimulated PKB activation.
    EMBO J. 2002 Oct 1;21(19):5097-108 PMID: 12356726
  27. The phosphoinositide 3-kinase pathway.
    Science. 2002 May 31;296(5573):1655-7 PMID: 12040186
  28. Phosphoinositide 3-kinase C2alpha is activated upon smooth muscle cell migration and regulated by alpha(v)beta(3) integrin engagement.
    Biochem Biophys Res Commun. 2002 Sep 20;297(2):261-6 PMID: 12237112
  29. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus.
    Hum Gene Ther. 1996 Aug 1;7(12):1405-13 PMID: 8844199
  30. A type II phosphoinositide 3-kinase is stimulated via activated integrin in platelets. A source of phosphatidylinositol 3-phosphate.
    J Biol Chem. 1998 Jun 5;273(23):14081-4 PMID: 9603905
  31. Class II phosphoinositide 3-kinases are downstream targets of activated polypeptide growth factor receptors.
    Mol Cell Biol. 2000 Jun;20(11):3817-30 PMID: 10805725
  32. Topographical expression of class IA and class II phosphoinositide 3-kinase enzymes in normal human tissues is consistent with a role in differentiation.
    BMC Clin Pathol. 2003 Oct 16;3(1):4 PMID: 14563213
  33. Recruitment of the class II phosphoinositide 3-kinase C2beta to the epidermal growth factor receptor: role of Grb2.
    Mol Cell Biol. 2001 Oct;21(19):6660-7 PMID: 11533253
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
2005-12-00
Pages
11122-30
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC1316983
Subset
IM
Grants
NIAMS NIH HHS · R01 AR043799 · United States
NIAMS NIH HHS · AR43799 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com